A recent paper examines the circumstances in which public good outweighs the requirement that researchers receive individual consent to use a person's data.
The 2017 revisions to the Common Rule deal largely with improving the transparency and clarity of intended uses under the current standard of informed consent while introducing a new concept of "broad consent".
Increasingly, the scientific community is coming to realize the invaluable role that negative outcomes play in the understanding of medicine as a whole.
New methods of obtaining consent are offering options that can bridge the geographic distances between researcher and participant, while making study information more easily accessible.
Clinical Pain Advisor Articles
- Non-Opioid Therapies for Pain Management in the ED
- CBT vs Pain Education for Chronic Pain in Low-Income Clinics
- Betel Quid Addiction and Implications for Substance Use Disorder
- Factors Predicting Pain Outcomes After TKR for Knee Osteoarthritis
- Peripherally Acting Opioid and Cannabinoid May Be Effective for Neuropathic Pain
- Exploring the Connections Between Neuropathic Pain and Comorbid Mood Disorders
- Medical Marijuana Laws, Dispensaries May Reduce Deaths From Opioid Overdose
- Ketamine Infusion May Be Effective for the Short-Term Relief of CRPS-Associated Pain
- An Avenue for the Development of Opioid Adjuncts for Enhanced Analgesia, Reduced Abuse Potential
- Peripheral Neuropathy Management in the Primary Care Setting: A Guide
- Once-Monthly Erenumab Injections May Be Effective for Episodic Migraine Prophylaxis
- The Pros and Cons of Direct-to-Consumer Genetic Testing
- Predicting Best Outcomes of Intra-Articular Hyaluronic Acid Treatment in Knee OA
- Virtual Reality as a Distraction From Pain During Medical Procedures
- Low Back Pain: Contributing Factors, Prophylactic Strategies, and Effective Treatments